Loading…

Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016

Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-07, Vol.13 (7), p.e0201171-e0201171
Main Authors: Ongwandee, Sumet, Lertpiriyasuwat, Cheewanan, Khawcharoenporn, Thana, Chetchotisak, Ploenchan, Thiansukhon, Ekkachai, Leerattanapetch, Niramon, Leungwaranan, Banlang, Manopaiboon, Chomnad, Phoorisri, Thanongsri, Visavakum, Prin, Jetsawang, Bongkoch, Poolsawat, Monsicha, Nookhai, Somboon, Vasanti-Uppapokakorn, Monthinee, Karuchit, Samart, Kittinunvorakoon, Chonticha, Mock, Philip, Prybylski, Dimitri, Sukkul, Ake-Chittra, Roels, Thierry, Martin, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV testing, help those who test positive start antiretroviral therapy, and increase access to pre-exposure prophylaxis (PrEP). We implemented rapid HIV testing and trained staff on immediate antiretroviral initiation at the five hospitals and offered PrEP at two hospitals. We recruited MSM and transgender women who walked-in to clinics and used a peer-driven intervention to expand recruitment. We used logistic regression to determine factors associated with prevalent HIV infection and the decision to start antiretroviral therapy and PrEP. During 2015 and 2016, 1880 people enrolled. Participants recruited by peers were younger (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0201171